Development and application of a new simulation model for COVID-19
$167,814R01FY2021AINIH
Massachusetts General Hospital, Boston MA
Investigators
Linked publications & trials
Paper 39107832Paper 39079827Paper 38915130Paper 38913762Paper 38728022Paper 38406181Paper 38329107Paper 38015507Paper 37963069Paper 37823865Paper 37601728Paper 37590260Paper 37523048Paper 37008565Paper 36478076Paper 36477564Paper 36268576Paper 35817068Paper 35793913Paper 35279115Paper 34817856Paper 34473294Paper 34189158Paper 34113690Paper 33564779Paper 33547993Paper 33347322Paper 32945845Paper 32730625Paper 32286656Paper 32150602Paper 32011622Paper 31975656Paper 31929403Paper 31909083Paper 31900813Paper 31131623Paper 31085063Paper 31055599Paper 30934067Paper 30865169Paper 30312374Paper 30173667Paper 29273141Paper 29141153Paper 29029344Paper 28975270Paper 28838064Paper 28699382Paper 28605504Paper 28605418Paper 28480259Paper 28329243Paper 27920163Paper 27815384Paper 27469972Paper 27177151Paper 26830283Paper 26651525Paper 26365741Paper 25820703Paper 23318310Paper 23208165Paper 22878419Paper 22180526Paper 22008655Paper 21126955Paper 20976112Paper 20100977Paper 18190295Paper 18156991Paper 17760736Paper 17288069Paper 17254508Paper 17146064Paper 17133193Paper 17063130Paper 17051505Paper 16983134Paper 16897416Paper 16841136Paper 16798621Paper 16741877Paper 16547789Paper 16475889Paper 16206108Paper 15951459Paper 15851916Paper 15751762Paper 15745728Paper 15703423Paper 15364455Paper 15307008Paper 15156451Paper 14689354Paper 14656616Paper 14570299Paper 14513418Paper 12594648Paper 12553480
Abstract
This project leverages the Cost-effectiveness of Preventing AIDS Complications (CEPAC) team to develop a novel computer microsimulation model of COVID-19 disease to assess the impact of testing and treatment interventions in diverse populations in the United States, and to conduct both modeling and registry work to inform that model.
View original record on NIH RePORTER →